Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The frequency of POLE-mutation in endometrial carcinoma and prognostic implications: a systemic review and meta-analysis
Alaa Salah Jumaah, Mais Muhammed Salim, Hawraa Sahib Al‐Haddad, et al.
Journal of Pathology and Translational Medicine (2020) Vol. 54, Iss. 6, pp. 471-479
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Endometrial cancer
Vicky Makker, Helen Mackay, Isabelle Ray‐Coquard, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 371
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology
Nadeem R. Abu‐Rustum, Catheryn M. Yashar, Rebecca C. Arend, et al.
Journal of the National Comprehensive Cancer Network (2023) Vol. 21, Iss. 2, pp. 181-209
Closed Access | Times Cited: 359
Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta‐analysis
Jessica N. McAlpine, Derek S. Chiu, Remi A. Nout, et al.
Cancer (2021) Vol. 127, Iss. 14, pp. 2409-2422
Open Access | Times Cited: 112
Potential of molecular classification to guide fertility-sparing management among young patients with endometrial cancer
Núria Agustí, Alexa Kanbergs, Roni Nitecki
Gynecologic Oncology (2024) Vol. 185, pp. 121-127
Open Access | Times Cited: 10
Translating biological insights into improved management of endometrial cancer
Jeffrey How, Amir A. Jazaeri, Shannon N. Westin, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 11, pp. 781-800
Closed Access | Times Cited: 6
The Role of Immunohistochemistry Markers in Endometrial Cancer with Mismatch Repair Deficiency: A Systematic Review
Amélia Favier, Justine Varinot, Cathérine Uzan, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3783-3783
Open Access | Times Cited: 22
Assessing the New 2020 ESGO/ESTRO/ESP Endometrial Cancer Risk Molecular Categorization System for Predicting Survival and Recurrence
Yung‐Taek Ouh, Yoonji Oh, Jinwon Joo, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 965-965
Open Access | Times Cited: 4
The clinicopathology and survival characteristics of patients with POLE proofreading mutations in endometrial carcinoma: A systematic review and meta-analysis
Alaa Salah Jumaah, Hawraa Sahib Al‐Haddad, Katherine McAllister, et al.
PLoS ONE (2022) Vol. 17, Iss. 2, pp. e0263585-e0263585
Open Access | Times Cited: 17
Development of Antibody–Drug Conjugates for Malignancies of the Uterine Corpus: A Review
T. Yamanaka, Tadaaki Nishikawa, Hiroshi Yoshida
Cells (2025) Vol. 14, Iss. 5, pp. 333-333
Open Access
A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer: insights from ProMisE molecular classification system
Yohei Chiba, Masahiro Kagabu, Mitsumasa Osakabe, et al.
Japanese Journal of Clinical Oncology (2024) Vol. 54, Iss. 4, pp. 424-433
Closed Access | Times Cited: 3
The Clinical and Pathological Characteristics of POLE-Mutated Endometrial Cancer: A Comprehensive Review
Xiaohong Yao, Min Feng, Wei Wang
Cancer Management and Research (2024) Vol. Volume 16, pp. 117-125
Open Access | Times Cited: 3
The clinicopathological characteristics of POLE-mutated/ultramutated endometrial carcinoma and prognostic value of POLE status: a meta-analysis based on 49 articles incorporating 12,120 patients
Qing Wu, Nianhai Zhang, Xianhe Xie
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 12
CircRNA-miRNA-mRNA interactome analysis in endometrial cancer
Tikam Chand Dakal, Abhishek Kumar, Pawan Kumar Maurya
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-12
Closed Access | Times Cited: 7
Circumcision Complications
Feride Mehmetoğlu
Özgür Yayınları eBooks (2023)
Open Access | Times Cited: 6
Mismatch repair deficiency and clinicopathological characteristics in endometrial carcinoma: a systematic review and meta-analysis
Alaa Salah Jumaah, Hawraa Sahib Al‐Haddad, Mais Muhammed Salem, et al.
Journal of Pathology and Translational Medicine (2021) Vol. 55, Iss. 3, pp. 202-211
Open Access | Times Cited: 13
Fast and reliable Sanger POLE sequencing protocol in FFPE tissues of endometrial cancer
Izabela Łaczmańska, Dagmara Michalowska, Marcin Jędryka, et al.
Pathology - Research and Practice (2023) Vol. 242, pp. 154315-154315
Closed Access | Times Cited: 4
PD-1 and PD-L1 Blockade plus Chemotherapy in Endometrial Cancer
Paz Polak, Lili Fu, William D. Foulkes
New England Journal of Medicine (2023) Vol. 389, Iss. 9, pp. 866-868
Closed Access | Times Cited: 4
High prevalence of “non‐pathogenic” POLE mutation with poor prognosis in a cohort of endometrial cancer from South India
Santhosh Kuriakose, Dhananjayan Dhanasooraj, P. M. Shiny, et al.
International Journal of Gynecology & Obstetrics (2024) Vol. 166, Iss. 3, pp. 1263-1272
Closed Access | Times Cited: 1
Accelerated clinical response achieved by combining short-term tumor-directed photodynamic therapy with immunotherapy-based systemic therapies in synchronous colorectal cancer with MSI-H and POLE mutation: a case report
Yuhan Wang, Lei Gao, Bin Ma, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Morphomolecular Correlation and Clinicopathologic Analysis in Endometrial Carcinoma
Göksenil Bülbül, Tekincan Çağrı Aktaş, Anıl Aysal Ağalar, et al.
International Journal of Gynecological Pathology (2024) Vol. 43, Iss. 6, pp. 535-556
Closed Access | Times Cited: 1
Prognostic implications of immunohistochemistry in patients with endometrial cancer
Maria-Bianca Anca-Stanciu, Andrei Manu, Maria Victoria Olinca, et al.
Romanian Journal of Morphology and Embryology (2024) Vol. 65, Iss. 2, pp. 185-193
Open Access | Times Cited: 1
Enhanced polymerase activity permits efficient synthesis by cancer-associated DNA polymerase ϵ variants at low dNTP levels
Stephanie R. Barbari, Annette K. Beach, Joel G Markgren, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 14, pp. 8023-8040
Open Access | Times Cited: 6
The hereditary N363K POLE exonuclease mutant extends PPAP tumor spectrum to glioblastomas by causing DNA damage and aneuploidy in addition to increased mismatch mutagenicity
Guillaume Labrousse, Pierre Vande Perre, Genı́s Parra, et al.
NAR Cancer (2023) Vol. 5, Iss. 2
Open Access | Times Cited: 3
New boundaries for fertility sparing management in endometrial cancer
Alexandros Rodolakis, Vasilios Pergialiotis, Nikolaos Thomakos
Current Opinion in Oncology (2023) Vol. 35, Iss. 5, pp. 394-400
Closed Access | Times Cited: 3
The Advantages of Next-Generation Sequencing Molecular Classification in Endometrial Cancer Diagnosis
Daniela Rivera, Michele Paudice, Giulia Accorsi, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7236-7236
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top